This information collection request
supports FDA's regulations regarding new animal drugs for
investigational uses. Respondents to the collection are new animal
drug sponsors.
This collection reflects an
overall increase attributed to an increase in respondents. This is
explained more fully in the agency's supporting statement at Q15.
The agency also notes that the cost to industry for the information
collection was not previously included in our last submission;
however we have included that information in this request at
Question 12b.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.